Pfizer-BioNTech COVID-19 vaccine
mRNA vaccine, first authorised in the UK on 2 December 2020; 95 per cent effective in its phase 3 trial.
ConceptAlso known as BNT162b2, Comirnaty
- Identifiers
- Wikidata Q97154240
mRNA vaccine, first authorised in the UK on 2 December 2020; 95 per cent effective in its phase 3 trial.
ConceptAlso known as BNT162b2, Comirnaty
